Abstract:A major challenge in human genetics is to identify the molecular mechanisms of trait-associated and disease-associated variants. To achieve this, quantitative trait locus (QTL) mapping of genetic variants with intermediate molecular phenotypes such as gene expression and splicing have been widely adopted 1,2 . However, despite successes, the molecular basis for a considerable fraction of trait-associated and disease-associated variants remains unclear 3,4 . Here we show that ADAR-mediated adenosine-to-inosine RNA editing, a post-transcriptional event vital for suppressing cellular double-stranded RNA (dsRNA)-mediated innate immune interferon responses 5,6,7,8,9,10,11 , is an important potential mechanism underlying genetic variants associated with common inflammatory diseases. We identified and characterized 30,319 cis- RNA editing QTLs (edQTLs) across 49 human tissues. These edQTLs were significantly enriched in genome-wide association study signals for autoimmune and immune-mediated diseases. Colocalization analysis of edQTLs with disease risk loci further pinpointed key, putatively immunogenic dsRNAs formed by expected inverted repeat Alu elements as well as unexpected, highly over-represented cis -natural antisense transcripts. Furthermore, inflammatory disease risk variants, in aggregate, were associated with reduced editing of nearby dsRNAs and induced interferon responses in inflammatory diseases. This unique directional effect agrees with the established mechanism that lack of RNA editing by ADAR1 leads to the specific activation of the dsRNA sensor MDA5 and subsequent interferon responses and inflammation 7,8,9 . Our findings implicate cellular dsRNA editing and sensing as a previously underappreciated mechanism of common inflammatory diseases.

Possible etiological role of impaired endogenous double strand RNA editing in β‐cells in type 1 diabetes

Disrupted RNA editing in beta cells mimics early-stage type 1 diabetes

Molecular Mechanism of Islet Β-Cell Functional Alternations During Type 2 Diabetes.

The interferon regulatory factors, a double-edged sword, in the pathogenesis of type 1 diabetes

Transcriptional Control of Pancreatic Β-Cell Identity and Plasticity During the Pathogenesis of Type 2 Diabetes.

Heterogeneous Development of Β-Cell Populations in Diabetes-Resistant and Susceptible Mice

Type I and II Interferon Receptors Differentially Regulate Type 1 Diabetes Susceptibility in Male Versus Female NOD Mice

MicroRNAs in Type 1 Diabetes: Complex Interregulation of the Immune System, β Cell Function and Viral Infections

miRNA-Mediated Immune Regulation in Islet Autoimmunity and Type 1 Diabetes

Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus

Role of Innate Immune Cells in Type 1 Diabetes Mellitus

Type-1 interferon induced cross-regulation of IL-10 function: a novel mechanism in type 1 diabetes development

Proinflammatory signaling in islet β cells propagates invasion of pathogenic immune cells in autoimmune diabetes

Presumption of innocence for beta cells: why are they vulnerable autoimmune targets in type 1 diabetes?

miRNA Regulation of T Cells in Islet Autoimmunity and Type 1 Diabetes

RNA editing underlies genetic risk of common inflammatory diseases

Single-Cell Transcriptome Profiling of Pancreatic Islets From Early Diabetic Mice Identifies Anxa10 for Ca2+ Allostasis Toward β-Cell Failure

The IFIH1-A946T risk variant promotes diabetes in a sex-dependent manner

Knockdown of IFNAR2 reduces the inflammatory response in mouse model of type 1 diabetes

Innate Immunity in Type 1 Diabetes

β cell ER stress and the implications for immunogenicity in type 1 diabetes